KISQALI

NDC 0078-0874 · Novartis Pharmaceuticals Corporation

Generic nameribociclib

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)RIBOCICLIB SUCCINATE

Strength200 mg/1

Pharmacologic classCytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]

Marketing categoryNDA

Packages

0078-0874-63 — 3 BLISTER PACK in 1 CARTON (0078-0874-63) / 21 TABLET, FILM COATED in 1 BLISTER PACK (0078-0874-21)

FDA lists these products with the same active ingredient.

0078-0860 — ribociclib, 0078-0867 — ribociclib

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.